{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:40:11Z","timestamp":1771677611837,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"DOI":"10.7759\/cureus.46796","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:31:00Z","timestamp":1696955460000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Metastatic Ampullary Adenocarcinoma Following the Whipple Procedure"],"prefix":"10.7759","author":[{"given":"Aboud","family":"Kaliounji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"Kaliounji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Farraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nischal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy I.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28050293","article-title":"Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges","volume":"28","author":"Rizzo A","year":"2021","unstructured":"Rizzo A, Dadduzio V, Lombardi L, Ricci AD, Gadaleta-Caldarola G. Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges. Curr Oncol. 2021, 28:3393-402. 10.3390\/curroncol28050293","journal-title":"Curr Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.112","article-title":"Ampullary cancer: an overview","volume":"34","author":"Ahn DH","year":"2014","unstructured":"Ahn DH, Bekaii-Saab T. Ampullary cancer: an overview. Am Soc Clin Oncol Educ Book. 2014, 34:112-5. 10.14694\/EdBook_AM.2014.34.112","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7709-5","article-title":"Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma","volume":"29","author":"Yokoyama N","year":"2005","unstructured":"Yokoyama N, Shirai Y, Wakai T, Nagakura S, Akazawa K, Hatakeyama K. Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma. World J Surg. 2005, 29:519-23. 10.1007\/s00268-004-7709-5","journal-title":"World J Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-251","article-title":"Ampullary adenocarcinoma - differentiation matters","volume":"8","author":"Schirmacher P","year":"2008","unstructured":"Schirmacher P, B\u00fcchler MW. Ampullary adenocarcinoma - differentiation matters. BMC Cancer. 2008, 8:251. 10.1186\/1471-2407-8-251","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0034","article-title":"Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Chiorean EG","year":"2023","unstructured":"Chiorean EG, Chiaro MD, Tempero MA, et al.. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:753-82. 10.6004\/jnccn.2023.0034","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S372053","article-title":"Remission from the 5-Fu-based chemotherapy to gemcitabine-based chemotherapy-based on the pathological classification of periampullary carcinoma: a case report and literature review","volume":"15","author":"Hu W","year":"2022","unstructured":"Hu W, Duan Z, Zhang Y, et al.. Remission from the 5-Fu-based chemotherapy to gemcitabine-based chemotherapy-based on the pathological classification of periampullary carcinoma: a case report and literature review. Onco Targets Ther. 2022, 15:891-6. 10.2147\/OTT.S372053","journal-title":"Onco Targets Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3624-6","article-title":"Association of adjuvant therapy with improved survival in ampullary cancer: a national cohort study","volume":"22","author":"Nassour I","year":"2018","unstructured":"Nassour I, Hynan LS, Christie A, et al.. Association of adjuvant therapy with improved survival in ampullary cancer: a national cohort study. J Gastrointest Surg. 2018, 22:695-702. 10.1007\/s11605-017-3624-6","journal-title":"J Gastrointest Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/190039-a-rare-case-of-metastatic-ampullary-adenocarcinoma-following-the-whipple-procedure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:22Z","timestamp":1707509422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/190039-a-rare-case-of-metastatic-ampullary-adenocarcinoma-following-the-whipple-procedure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.46796","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}